Downstream Processing Market Is Poised To Reach $22.03 Billion by 2021 | Top Companies Are Thermo Fisher Scientific Inc.,GE Healthcare, & Sartorius Stedim Biotech

CITY – Northbrook, Country – USA, 2020-Feb-18 — /EPR Network/ —

The global downstream processing market size is poised to reach USD 22.03 Billion by 2021 from USD 10.32 Billion in 2016, at a CAGR of 16.4% from 2016 to 2021. It provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue.

Browse 68 market data tables and 40 figures spread through 139 pages and in-depth TOC on “Downstream Processing Market – Global Forecast to 2021”

Request Sample Insights: https://www.marketsandmarkets.com/requestsampleNew.asp?id=73180930

Continuous advancements in the chromatography columns and resins such as single-use and pre-packed chromatography columns and resins are revenue-generating pockets for the downstream processing market. Developing markets in the Asia-Pacific region such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore are also revenue pockets for market players, due to increasing investments in the healthcare industry by key market players. The global downstream processing market is segmented on the basis of technique, product, application, end user, and region.

Based on product, the market is broadly classified into chromatography columns and resins, filters, membrane adsorbers, single-use products, and other products (consumables and accessories). The chromatography columns and resins segment is estimated to grow at the highest CAGR during the forecast period. The constant need for newer and different types of columns and resins is likely to fuel market growth.

Based on application, the market is categorized into monoclonal antibody (mAbs) production, vaccine production, insulin production, immunoglobulin production, erythropoietin production, and other applications. The monoclonal antibody (mAbs) production segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the increasing R&D expenditure to produce mAbs due to the rising demand for protein therapeutics.

Explore In-depth Insights: https://www.marketsandmarkets.com/Market-Reports/downstream-processing-market-73180930.html

Based on end user, the market is segmented into biopharmaceutical manufacturers and contract manufacturing organizations (CMOs). The CMOs segment is expected to grow at the highest CAGR during the forecast period. The shifting R&D focus from upstream processing and drug discovery to downstream processing and increasing outsourcing of biopharmaceutical and generic manufacturing to CMOs are expected to drive the growth of this end-user segment.

Scope of the Report

• The market study doesn’t cover the market size in terms of volume
• Some companies in this market are privately owned and their revenues are not available in the public domain. Hence, revenue for those companies are not included in this report
• Company developments not reported in the public domain are not included in this report

Feel Free To Speak with Our Expert: 
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=73180930

The downstream processing market is dominated by established players such as Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), and Danaher Corporation (U.S.).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. 

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com